AG˹ٷ

STOCK TITAN

[144] Clover Health Investments, Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Clover Health Investments, Corp. (CLOV) has filed a Form 144 indicating a proposed sale of insider shares.

  • Shares to be sold: 2,012 common shares
  • Estimated market value: $5,150.72
  • Broker: Morgan Stanley Smith Barney LLC, New York
  • Planned execution date: 07/07/2025 on NASDAQ
  • Total shares outstanding: 416,541,578 (sale equals ~0.0005% of float)

The filing also lists recent 10b5-1 sales by the same insider, Jamie Reynoso, totaling 40,239 shares for gross proceeds of $109,504.30 across two transactions on 06/17/2025 and 07/03/2025.

Because the proposed sale is immaterial relative to the company’s share count, the market impact is expected to be minor; however, continual insider selling can be perceived negatively by some investors.

Clover Health Investments, Corp. (CLOV) ha presentato un modulo 144 che indica una proposta di vendita di azioni da parte di un insider.

  • Azioni da vendere: 2.012 azioni ordinarie
  • Valore di mercato stimato: 5.150,72 $
  • Broker: Morgan Stanley Smith Barney LLC, New York
  • Data prevista per l’esecuzione: 07/07/2025 sul NASDAQ
  • Totale azioni in circolazione: 416.541.578 (la vendita corrisponde a circa lo 0,0005% del flottante)

Il modulo riporta anche vendite recenti ai sensi della regola 10b5-1 effettuate dallo stesso insider, Jamie Reynoso, per un totale di 40.239 azioni, con ricavi lordi di 109.504,30 $ in due transazioni avvenute il 17/06/2025 e il 03/07/2025.

Poiché la vendita proposta è irrilevante rispetto al numero totale di azioni della società, l’impatto sul mercato è previsto come minimo; tuttavia, vendite continue da parte degli insider possono essere percepite negativamente da alcuni investitori.

Clover Health Investments, Corp. (CLOV) ha presentado un Formulario 144 que indica una propuesta de venta de acciones por parte de un insider.

  • Acciones a vender: 2,012 acciones ordinarias
  • Valor estimado de mercado: 5,150.72 $
  • Corredor: Morgan Stanley Smith Barney LLC, Nueva York
  • Fecha planificada para la ejecución: 07/07/2025 en NASDAQ
  • Total de acciones en circulación: 416,541,578 (la venta equivale a aproximadamente el 0.0005% del flotante)

El formulario también lista ventas recientes bajo la regla 10b5-1 realizadas por el mismo insider, Jamie Reynoso, por un total de 40,239 acciones y unos ingresos brutos de 109,504.30 $ en dos transacciones el 17/06/2025 y el 03/07/2025.

Dado que la venta propuesta es insignificante en relación con el número total de acciones de la empresa, se espera que el impacto en el mercado sea menor; sin embargo, ventas continuas por parte de insiders pueden ser percibidas negativamente por algunos inversores.

Clover Health Investments, Corp. (CLOV)가 Form 144� 제출했습니다, 이는 내부� 주식 매각 제안� 나타냅니�.

  • 매각 예정 주식 �: 보통� 2,012�
  • 추정 시장 가�: $5,150.72
  • 중개�: Morgan Stanley Smith Barney LLC, 뉴욕
  • 예정 실행 날짜: 2025� 7� 7�, NASDAQ
  • � 발행 주식 �: 416,541,578� (매각 비율은 � 0.0005%� 유동 주식)

해당 신고서에� 동일 내부자인 Jamie Reynoso� 최근 10b5-1 규정� 따른 매각 내역� 포함되어 있으�, 2025� 6� 17일과 7� 3� � 건의 거래에서 � 40,239주를 매각하여 � 수익 $109,504.30� 기록했습니다.

제안� 매각 규모가 회사 전체 주식 수에 비해 미미하여 시장� 미치� 영향은 작을 것으� 예상되나, 지속적� 내부� 매도� 일부 투자자들에게 부정적으로 인식� � 있습니다.

Clover Health Investments, Corp. (CLOV) a déposé un formulaire 144 indiquant une proposition de vente d’actions par un initié.

  • Actions à vendre : 2 012 actions ordinaires
  • Valeur marchande estimée : 5 150,72 $
  • Intermédiaire : Morgan Stanley Smith Barney LLC, New York
  • Date prévue d’exécution : 07/07/2025 sur le NASDAQ
  • Nombre total d’actions en circulation : 416 541 578 (la vente représente environ 0,0005 % du flottant)

Le dépôt mentionne également des ventes récentes selon la règle 10b5-1 du même initié, Jamie Reynoso, totalisant 40 239 actions pour un produit brut de 109 504,30 $ lors de deux transactions les 17/06/2025 et 03/07/2025.

Étant donné que la vente proposée est peu significative par rapport au nombre total d’actions de la société, l’impact sur le marché devrait être mineur ; toutefois, des ventes répétées par les initiés peuvent être perçues négativement par certains investisseurs.

Clover Health Investments, Corp. (CLOV) hat ein Formular 144 eingereicht, das einen geplanten Verkauf von Insider-Aktien anzeigt.

  • Zu verkaufende Aktien: 2.012 Stammaktien
  • Geschätzter Marktwert: 5.150,72 $
  • Broker: Morgan Stanley Smith Barney LLC, New York
  • Geplanter Ausführungstermin: 07.07.2025 an der NASDAQ
  • Gesamtanzahl der ausstehenden Aktien: 416.541.578 (Verkauf entspricht ca. 0,0005 % des Streubesitzes)

Die Einreichung listet auch kürzliche Verkäufe gemäß 10b5-1 desselben Insiders, Jamie Reynoso, mit insgesamt 40.239 Aktien und Bruttoerlösen von 109.504,30 $ aus zwei Transaktionen am 17.06.2025 und 03.07.2025.

Da der geplante Verkauf im Verhältnis zur Gesamtaktienzahl des Unternehmens unerheblich ist, wird eine geringe Marktbeeinflussung erwartet; dennoch können kontinuierliche Insider-Verkäufe von einigen Investoren negativ wahrgenommen werden.

Positive
  • Volume immaterial: 2,012 shares represent just 0.0005% of outstanding stock, implying negligible dilution.
Negative
  • Continued insider selling: Insider has already sold 40,239 shares this quarter, which may be perceived as bearish sentiment.

Insights

TL;DR: Small Form 144 sale; negligible dilution but signals ongoing insider selling.

The notice covers a sale of just 2,012 shares (<$6k), representing a fraction of CLOV’s 416.5 million shares. While quantitatively insignificant, it follows two earlier 10b5-1 sales totaling 40k shares this quarter, which could concern investors tracking sentiment. No financial metrics are provided; thus, valuation impact is minimal. Overall, the filing is routine and not likely to affect price absent larger trends.

TL;DR: Routine compliance filing; shows transparent 10b5-1 trading plan.

The insider certifies lack of undisclosed adverse information and references a 10b5-1 plan, satisfying regulatory best practices. Volume sold is trivial, reinforcing that this is standard liquidity management rather than a strategic exit. Governance risk is low, but cumulative insider sales may warrant monitoring if pace accelerates.

Clover Health Investments, Corp. (CLOV) ha presentato un modulo 144 che indica una proposta di vendita di azioni da parte di un insider.

  • Azioni da vendere: 2.012 azioni ordinarie
  • Valore di mercato stimato: 5.150,72 $
  • Broker: Morgan Stanley Smith Barney LLC, New York
  • Data prevista per l’esecuzione: 07/07/2025 sul NASDAQ
  • Totale azioni in circolazione: 416.541.578 (la vendita corrisponde a circa lo 0,0005% del flottante)

Il modulo riporta anche vendite recenti ai sensi della regola 10b5-1 effettuate dallo stesso insider, Jamie Reynoso, per un totale di 40.239 azioni, con ricavi lordi di 109.504,30 $ in due transazioni avvenute il 17/06/2025 e il 03/07/2025.

Poiché la vendita proposta è irrilevante rispetto al numero totale di azioni della società, l’impatto sul mercato è previsto come minimo; tuttavia, vendite continue da parte degli insider possono essere percepite negativamente da alcuni investitori.

Clover Health Investments, Corp. (CLOV) ha presentado un Formulario 144 que indica una propuesta de venta de acciones por parte de un insider.

  • Acciones a vender: 2,012 acciones ordinarias
  • Valor estimado de mercado: 5,150.72 $
  • Corredor: Morgan Stanley Smith Barney LLC, Nueva York
  • Fecha planificada para la ejecución: 07/07/2025 en NASDAQ
  • Total de acciones en circulación: 416,541,578 (la venta equivale a aproximadamente el 0.0005% del flotante)

El formulario también lista ventas recientes bajo la regla 10b5-1 realizadas por el mismo insider, Jamie Reynoso, por un total de 40,239 acciones y unos ingresos brutos de 109,504.30 $ en dos transacciones el 17/06/2025 y el 03/07/2025.

Dado que la venta propuesta es insignificante en relación con el número total de acciones de la empresa, se espera que el impacto en el mercado sea menor; sin embargo, ventas continuas por parte de insiders pueden ser percibidas negativamente por algunos inversores.

Clover Health Investments, Corp. (CLOV)가 Form 144� 제출했습니다, 이는 내부� 주식 매각 제안� 나타냅니�.

  • 매각 예정 주식 �: 보통� 2,012�
  • 추정 시장 가�: $5,150.72
  • 중개�: Morgan Stanley Smith Barney LLC, 뉴욕
  • 예정 실행 날짜: 2025� 7� 7�, NASDAQ
  • � 발행 주식 �: 416,541,578� (매각 비율은 � 0.0005%� 유동 주식)

해당 신고서에� 동일 내부자인 Jamie Reynoso� 최근 10b5-1 규정� 따른 매각 내역� 포함되어 있으�, 2025� 6� 17일과 7� 3� � 건의 거래에서 � 40,239주를 매각하여 � 수익 $109,504.30� 기록했습니다.

제안� 매각 규모가 회사 전체 주식 수에 비해 미미하여 시장� 미치� 영향은 작을 것으� 예상되나, 지속적� 내부� 매도� 일부 투자자들에게 부정적으로 인식� � 있습니다.

Clover Health Investments, Corp. (CLOV) a déposé un formulaire 144 indiquant une proposition de vente d’actions par un initié.

  • Actions à vendre : 2 012 actions ordinaires
  • Valeur marchande estimée : 5 150,72 $
  • Intermédiaire : Morgan Stanley Smith Barney LLC, New York
  • Date prévue d’exécution : 07/07/2025 sur le NASDAQ
  • Nombre total d’actions en circulation : 416 541 578 (la vente représente environ 0,0005 % du flottant)

Le dépôt mentionne également des ventes récentes selon la règle 10b5-1 du même initié, Jamie Reynoso, totalisant 40 239 actions pour un produit brut de 109 504,30 $ lors de deux transactions les 17/06/2025 et 03/07/2025.

Étant donné que la vente proposée est peu significative par rapport au nombre total d’actions de la société, l’impact sur le marché devrait être mineur ; toutefois, des ventes répétées par les initiés peuvent être perçues négativement par certains investisseurs.

Clover Health Investments, Corp. (CLOV) hat ein Formular 144 eingereicht, das einen geplanten Verkauf von Insider-Aktien anzeigt.

  • Zu verkaufende Aktien: 2.012 Stammaktien
  • Geschätzter Marktwert: 5.150,72 $
  • Broker: Morgan Stanley Smith Barney LLC, New York
  • Geplanter Ausführungstermin: 07.07.2025 an der NASDAQ
  • Gesamtanzahl der ausstehenden Aktien: 416.541.578 (Verkauf entspricht ca. 0,0005 % des Streubesitzes)

Die Einreichung listet auch kürzliche Verkäufe gemäß 10b5-1 desselben Insiders, Jamie Reynoso, mit insgesamt 40.239 Aktien und Bruttoerlösen von 109.504,30 $ aus zwei Transaktionen am 17.06.2025 und 03.07.2025.

Da der geplante Verkauf im Verhältnis zur Gesamtaktienzahl des Unternehmens unerheblich ist, wird eine geringe Marktbeeinflussung erwartet; dennoch können kontinuierliche Insider-Verkäufe von einigen Investoren negativ wahrgenommen werden.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many Clover Health (CLOV) shares are being sold under this Form 144?

2,012 common shares are slated for sale.

What is the approximate value of the proposed CLOV share sale?

The aggregate market value is $5,150.72.

When is the planned sale date for the CLOV shares?

The insider plans to sell on 07/07/2025.

Which broker is handling the CLOV Form 144 transaction?

Morgan Stanley Smith Barney LLC, New York.

How many CLOV shares are outstanding according to the filing?

The company reports 416,541,578 shares outstanding.

What recent insider sales of CLOV stock were disclosed?

Sales of 19,789 shares on 07/03/2025 and 20,450 shares on 06/17/2025, totaling 40,239 shares.
Clover Health Investments Corp

NASDAQ:CLOV

CLOV Rankings

CLOV Latest News

CLOV Latest SEC Filings

CLOV Stock Data

1.40B
400.24M
5.09%
22.38%
2.33%
Healthcare Plans
Hospital & Medical Service Plans
United States
JERSEY CITY